Thus, our studies reveal that KDM6B regulates the oncogenic CDK4/6-pRB-E2F pathway in MYCN-amplified neuroblastoma, revealing a mechanism of regulation of the E2F transcriptome by an epigenetic modulator. The gene discussed is KDM6B; the disease is neuroblastoma.